People
Frost & Sullivan names Abzena a market-leading ADC CDMO
18 March 2026 - Abzena, an end-to-end integrated contract development and manufacturing organisation (CDMO) for complex biologics and bioconjugates, announced on Tuesday it has been named a leader in ...
WuXi Biologics wins at 2026 Asia-Pacific Biopharma Excellence Awards for leadership in bioprocessing, manufacturing excellence, and digital innovation
13 March 2026 - WuXi Biologics ('WuXi Bio') (HK:2269), a global Contract Research, Development and Manufacturing Organization (CRDMO), announced on Thursday that it has received six prestigi...
Vulcan Two signs five-year ERP licence agreement to support ePharmacy expansion
11 March 2026 - Vulcan Two Group plc (LSE: VUL) has signed a five-year licence agreement with a global provider of cloud-based enterprise software to implement a central enterprise resource planning (...
SportsMed Physical Therapy named Physical Therapy Company of the Year
10 March 2026 - SportsMed Physical Therapy, a multi-disciplinary physical therapy company with 52 locations across New Jersey and Connecticut, said on Monday that it has been named 2026 Physical Thera...
Ensorcell adds new senior leadership team members
4 March 2026 - Ensorcell (ensorcell.bio), a US-based company focused on reimaging life science tools and solutions for the biopharmaceutical industry, announced on Tuesday the appointments of Geoff Ho...
GelMEDIX completes USD13m seed financing, announces first partnership
18 February 2026 - US biotechnology company GelMEDIX Inc announced on Tuesday the completion of a USD13m seed financing led by Safar Partners, with participation from HTL Biotechnology, Beacon Angels,...